News

Twirla, from Agile Therapeutics, has been seeking marketing approval from the FDA since 2012.

A new pooled cohort analysis supports the longheld threshold of < .70 FEV1:FVC ratio to indicate patient risks from COPD-related events.

Acer Therapeutics Inc. announced on Tuesday they received a CRL from the FDA regarding their NDA from celiprolol (Edsivo).

A recent study found that telerehabilitation was comparable to traditional in-clinic rehabilitation for stroke patients.

Hypoactive sexual desire disorder is currently the most common form of sexual dysfunction among women in the US. There's also limited treatment options for it.

Recent analysis of 3 trials found that CERT2 showed comparable and synergistic predictive performance when compared with previously published CVD risk models.

Taking daily anticholinergic drugs when 55 or older increases the risk of dementia, according to this nested case-control study.

How advanced biologic care and symptom management programs fail patients more advanced in their disease.

A new retrospective cohort finds that patients with untreated obstructive sleep apnea face a two-fold greater risk of developing T2D.

The first-approved therapy for what clinicians once called the 'chronic' form of multiple sclerosis has changed standards of care.

Why biomarkers must be identified in patients with the progressive form of multiple sclerosis&mdash;and in what symptoms may those biomarkers best present.

A recent study found that plant-based diets can lead to changes in gut microbiota that correlate with weightloss and fat reduction.

The FDA had previously only certified Symdeko tablets for treatment of children aged 12 years and older.

Allergan announced approval of the sBLA for treatment in children from the ages of 2 to 17.

Investigators examined anti-VEGF injections claims data among Medicare Part B beneficiaries from 2012 to 2015 and found that aflibercept injections increased by 69% during that time.

The lead investigator of a new meta-analysis shared the critical need for further studies on psychotherapeutic versus pharmacological treatments for PTSD.

A recent study reviewed operating times of ophthalmic procedures before and after transition to a new EHR system in 2 outpatient departments and an ambulatory surgical center.

The endothelin receptor antagonist has proven benefits and safety for PAH patients burdened with liver or extrahepatic disease risks.

Analysis of the SURTAVI clinical trial revealed that TAVR and SAVR are both safe for patients with a CABG history.

A new meta-analysis showed that while psychotherapeutic treatments are generally preferred, there’s a dearth of data with which to defend that decision.

Survey of 3000 found that more than half of all respondents wish they knew more about heart failure but just 1 in 5 were likely to speak with their doctor out of fear of diagnosis or cost.

Both brick-and-mortar dermatology clinics as well as telehealth programs are limited and restricted by barriers to access.

A recent study from investigators at Michigan State University found that vitamin D supplementation was not associated with reduced risk of major cardiovascular events.

A team from Johns Hopkins assessed pediatric patients in Baltimore&mdash;an area with severe rates of asthma, indoor air pollution, and poor diets.

Christopher Sorli, MD, vice president of medical affairs at Sanofi, discusses the results of a recent trial examining insulin glargine plus lixisenatide.

A three-arm clinical trial of the SAMBA program showed that screening for and tailoring to individuals' asthma needs improves their condition management.

FDA has announced the approval of liraglutide injections for treatment of type 2 diabetes among pediatric patients.

The new approval allows for easier access to MRIs and direct audio streaming from Android devices.